QQ客服 官方微博 反馈留言

	A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
	Sheng, Xinan; Cui, Chuanliang; Mao, Lili; Chi, Zhihong; Si, Lu; Kong, Yan; Li, Siming; Lian, Bin; Gu, Kangsheng; Tao, Min
刊名	MOLECULAR THERAPY
	2013
卷号	21期号:7
ISSN号	1525-0016
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3448776
专题	昆明医科大学
推荐引用方式 GB/T 7714	Sheng, Xinan,Cui, Chuanliang,Mao, Lili,et al. A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma[J]. MOLECULAR THERAPY,2013,21(7).
APA	Sheng, Xinan.,Cui, Chuanliang.,Mao, Lili.,Chi, Zhihong.,Si, Lu.,...&Guo, Jun.(2013).A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma.MOLECULAR THERAPY,21(7).
MLA	Sheng, Xinan,et al."A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma".MOLECULAR THERAPY 21.7(2013).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。